Explore Hamps Bio IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Hamps Bio Limited is a diversified company operating in two primary segments: ethical marketing and distribution of pharmaceutical formulation products under the brand name "Hamps," and the manufacturing of freeze-dried and frozen food products under the brand "FzyEzy." The company’s pharmaceutical division provides a wide range of dosage forms, including tablets, syrups, capsules, injectables, oils, gels, and powders, serving both therapeutic and nutrition supplement needs. Simultaneously, the FMCG division focuses on freeze-dried and frozen fruits, vegetables, herbs, and flowers using advanced lyophilization technology. Hamps Bio Limited leverages a robust distribution network of over 50 distributors and prominent e-commerce platforms such as Amazon and Flipkart to market its products across India and internationally. With a portfolio of more than 180 products, the company has a strong presence in the pharmaceutical sector, covering eight Indian states and union territories, and the FMCG sector, spanning 22 states domestically and six countries globally. Hamps Bio Limited has achieved a well-balanced revenue mix with significant growth in its Freeze-Dried and Frozen Products (FDFP) segment, which now contributes 50.40% of total revenue as of October 31, 2024, up from 26.38% in Fiscal 2022, while maintaining consistent performance in its Pharma division.
Key Points:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 13 Dec - 17 Dec 2024 |
IPO Price Band | ₹51 per share |
Fresh Issue | ₹6.22 crore |
Offer For Sale | NIL |
Total IPO Size | ₹6.22 crore |
Face Value | ₹10 |
Listing On | BSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 13 Dec 2024 |
IPO Closing Date | 17 Dec 2024 |
Basis Of Allotment | 18 Dec 2024 |
Refunds | 19 Dec 2024 |
Demat Transfer | 19 Dec 2024 |
IPO Listing Date | 20 Dec 2024 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Oct 2024 |
---|---|---|---|---|
Total Income | 5.34 | 5.58 | 6.50 | 4.36 |
Total Expenses | 5.24 | 5.23 | 5.85 | 3.90 |
Net Profit/Loss | 0.12 | 0.36 | 0.50 | 0.34 |
NPM (*) | 2.28 | 6.44 | 7.73 | 7.99 |
Total Assets | 3.64 | 3.96 | 5.15 | 6.44 |
Total Liabilities | 2.64 | 2.60 | 1.77 | 2.73 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Oct 2024 |
---|---|---|---|---|
EPS | 0.51 | 1.50 | 1.76 | 1.09 |
ROE (%) | 12.32 | 30.31 | 21.14 | 16.65 |
ROCE (%) | 9.76 | 17.43 | 18.31 | 18.53 |
D/E Ratio | 2.03 | 1.27 | 0.31 | 0.37 |
Current Ratio | 0.74 | 0.59 | 1.73 | 1.38 |
EBITDA MARGIN (%) | 11.52 | 15.53 | 18.18 | 15.32 |
* Compiled from DRHP/RHP for valuation purposes.
No listed peers available for comparison.
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 0 |
Non-Institutional Investor (NII/HNI) | 758.27 |
Retail Individual Investor (RII) | 1342.04 |
Total | 1057 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
Bigshare Services Private Limited
Phone: +91 22-62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Hamps Bio Limited
2900/112, GIDC, Near Atul Limited, Ankelshwar, Bharuch – 393 002, Gujarat, India.
Phone: +91 8000006663
Email: info@hampsbio.com
Website: www.hampsbio.com